Among them, anti-SARS-CoV-2 neutralizing antibodies are of particular importance, as they can physically prevent the “entry complex” formed by the receptor-binding domain (RBD) of virus Spike and the human angiotensin-converting enzyme 2 (ACE2) expressed on target cells, thereby limiting infection spread and disease symptoms (9–11). The gene discussed is ACE2; the disease is infection.